Evidence map›Paper›PMID 28357285›Full record

ArticleMicrobial cell (Graz, Austria)2015

Modeling non-hereditary mechanisms of Alzheimer disease during apoptosis in yeast.

Ralf J Braun, Cornelia Sommer, Christine Leibiger, Romina J Gentier, Verónica I Dumit, Katrin Paduch, Tobias Eisenberg, Lukas Habernig, Gert Trausinger, Christoph Magnes and 6 more

Open access · goldAbstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial cell (Graz, Austria), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Different Expression Levels of Human Mutant Ubiquitin BFrontiers in molecular neuroscience · 2018
    Article
  2. Article
  3. Review
  4. Threading Granules in Freiburg. 2Microbial cell (Graz, Austria) · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Ralf J BraunInstitute of Cell Biology, University of Bayreuth, 95440 Bayreuth, Germany.
Cornelia SommerInstitute of Molecular Biosciences, NAWI Graz, University of Graz, 8010 Graz, Austria. ; BioTechMed-Graz, 8010 Graz, Austria.
Christine LeibigerInstitute of Cell Biology, University of Bayreuth, 95440 Bayreuth, Germany.
Romina J GentierDepartment of Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands.
Verónica I DumitFRIAS Freiburg Institute for Advanced Studies, Department of Dermatology, Medical Center, ZBSA Center for Biological Systems Analysis, BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany.
Katrin PaduchInstitute of Cell Biology, University of Bayreuth, 95440 Bayreuth, Germany.
Tobias EisenbergInstitute of Molecular Biosciences, NAWI Graz, University of Graz, 8010 Graz, Austria.
Lukas HabernigInstitute of Molecular Biosciences, NAWI Graz, University of Graz, 8010 Graz, Austria.
Gert TrausingerHEALTH Institute for Biomedicine and Health Sciences, Joanneum Research, 8010 Graz, Austria.
Christoph MagnesHEALTH Institute for Biomedicine and Health Sciences, Joanneum Research, 8010 Graz, Austria.
Thomas PieberHEALTH Institute for Biomedicine and Health Sciences, Joanneum Research, 8010 Graz, Austria. ; Division of Endocrinology and Metabolism, Medical University of Graz, 8036 Graz, Austria.
Frank SinnerHEALTH Institute for Biomedicine and Health Sciences, Joanneum Research, 8010 Graz, Austria. ; Division of Endocrinology and Metabolism, Medical University of Graz, 8036 Graz, Austria.
Jörn DengjelFRIAS Freiburg Institute for Advanced Studies, Department of Dermatology, Medical Center, ZBSA Center for Biological Systems Analysis, BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany.
Fred W V LeeuwenDepartment of Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands.
Guido KroemerApoptosis, Cancer & Immunity Laboratory, Team 11, Equipe labellisée Ligue contre le Cancer, INSERM Cordeliers Research Cancer, 75006 Paris, France. ; Institute of Cell Biology, University of Bayreuth, 95440 Bayreuth, Germany. ; Institute of Cell Biology, University of Bayreuth, 95440 Bayreuth, Germany. ; Institute of Cell Biology, University of Bayreuth, 95440 Bayreuth, Germany.
Frank MadeoInstitute of Molecular Biosciences, NAWI Graz, University of Graz, 8010 Graz, Austria. ; BioTechMed-Graz, 8010 Graz, Austria.
University of Bayreuth · DEJoanneum Research · ATMaastricht University · NLUniversity of Freiburg · DEUniversity of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impaired protein degradation and mitochondrial dysfunction are believed to contribute to neurodegenerative disorders, including Alzheimer disease (AD). In patients suffering from non-hereditary AD, UBB

Indexed as

agingapoptosisautophagycell deathmicrobesmicrobial researchmicrobiomeneurodegenerationunicellular organism

Identifiers

PMID28357285
PMCPMC5348975
OpenAlexW2143368975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.